Compare NNVC & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNVC | JFU |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 29.9M |
| IPO Year | 2008 | 2018 |
| Metric | NNVC | JFU |
|---|---|---|
| Price | $1.43 | $2.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 157.6K | 12.4K |
| Earning Date | 11-24-2026 | 12-09-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4,000.66 |
| Revenue Next Year | N/A | $5.00 |
| P/E Ratio | ★ N/A | $1.43 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.85 | $1.98 |
| 52 Week High | $1.93 | $9.48 |
| Indicator | NNVC | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 53.39 | 42.53 |
| Support Level | $1.23 | $2.06 |
| Resistance Level | $1.49 | $2.97 |
| Average True Range (ATR) | 0.10 | 0.27 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 59.26 | 28.00 |
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.
9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.